In 2017, Caroline was diagnosed with Stage IV, High-Risk Neuroblastoma: an aggressive, solid-tumor cancer that spread throughout almost all of her body, including her bone marrow. She completed a 2-year clinical trial (called DFMO) in April 2021, and relapsed in April 2022. She is currently a patient at the Monroe Carell Jr. Children's Hospital at Vanderbilt in Nashville, TN; this blog documents her journey.
Wednesday, February 20, 2019
Vanderbilt Admission - Immunotherapy Round 5
Caroline was admitted this evening for Round 5 (of 6) of Immunotherapy. We are hopeful this will be her LAST inpatient admission for cancer treatment; her next round of Immunotherapy will take place at home (oral medication). She will begin antibody therapy tomorrow morning, as well as get on a Dilaudid PCA 24/7 for pain management (pain is caused by the anti-body drug, Unituxin). We expect all the same side effects this round, as in the previous 4 rounds: high fever, extreme nerve pain, rash, loss of appetite, low oxygen levels, low blood pressure, nausea, diarrhea, etc. It will be a rough little stretch, but we hope and pray it’s doing everything to get her to an NED (no evidence of disease) scan in April.
For those that have asked about #carolinestrong shirts, there is a batch going to print in 2 days: click here for the link.
As always, many thanks for the prayers and support!
The Lantz Family
HUGE thank you to Michelle Prichard for the awesome door sign and room decorations...she's decorated every.single.room for ALL of Caroline's inpatient stays!